IP Library Granted Patent US 9,587,266
Granted Patent B2
US 9,587,266 · App. 13/984,506 · Granted Mar 7, 2017

Mutant luciferases

Inventors: Stephen C. Miller (Cambridge, MA); David Mofford (Marlborough, MA); Katryn Harwood (North Bethesda, MD)
Assignee: University of Massachusetts
C12Q1/66C12N9/0069C12Y113/12007A01K2267/0393C07K2319/00C07K2319/02C07K2319/23C07K2319/30C07K2319/31C07K2319/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,587,266
App. No.
13/984,506
Granted
Mar 7, 2017
Kind
B2
Abstract

Described are mutant luciferases, nucleic acids that encode them, cells and animals expressing them, methods of use thereof, and kits.

Claims (24)

1. A polypeptide comprising a mutant luciferase,

wherein said mutant luciferase is at least 95% identical to the full length of SEQ ID NO: 5 and comprises a lysine at position 218 and an alanine at position 342, and

wherein, compared to the luciferase of SEQ ID NO: 5, said mutant luciferase has improved bioluminescence using CycLuc2 as the substrate.

2. A kit comprising the polypeptide of claim 1 and a cognate substrate.

3. A method of producing bioluminescence in a sample, the method comprising:

providing a sample comprising the polypeptide of claim 1 ; and

contacting the sample with a cognate substrate.

4. The method of claim 3 , further comprising detecting bioluminescence in the sample.

5. The method of claim 3 , wherein the sample comprises a living cell, a living animal, a tissue or organ, or a cell or tissue extract.

6. A method of producing bioluminescence in a sample, the method comprising:

providing a sample comprising the polypeptide of claim 1 , and

contacting the sample with a substrate, wherein

the substrate is CycLuc1-8, MeNH-LH2, iBuNH-LH2, (3-hydroxypropyl)NH-LH2, or Me2N-LH2.

7. The method of claim 6 , further comprising detecting bioluminescence in the sample.

8. The method of claim 6 , further comprising obtaining an image of the bioluminescence in the sample.

9. The method of claim 6 , wherein the substrate is CycLuc1, CycLuc4, CycLuc2, or CycLuc7.

10. A kit for use in a method of producing bioluminescence in a sample, the kit comprising the polypeptide of claim 1 , and a substrate, wherein

the substrate is CycLuc1-8, MeNH-LH2, iBuNH-LH2, (3-hydroxypropyl)NH-LH2, or Me2N-LH2.

11. The kit of claim 10 , wherein the substrate is CycLuc1, CycLuc4, CycLuc2, or CycLuc7.

12. The mutant luciferase of claim 1 , wherein the cognate substrate is CycLuc2.

13. The kit of claim 2 , wherein the cognate substrate is CycLuc2.

14. The method of claim 3 , wherein the cognate substrate is CycLuc2.

15. The method of claim 6 , wherein the substrate is CycLuc2.

16. The kit of claim 10 , wherein the substrate is CycLuc2.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 21, 2017
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042303/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: MILLER, STEPHEN C.; MOFFORD, DAVID; HARWOOD, KATRYN
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 031904/0202 →
Continuity (2)
Provisional Application 61441136 · Feb 9, 2011
Related Publication 20140201855A1 · Jul 17, 2014